Literature DB >> 8871602

Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A.

I N Mbawuike1, C Acuna, D Caballero, K Pham-Nguyen, B Gilbert, P Petribon, M Harmon.   

Abstract

Old and young Balb/c mice, 24--26 and 2--4 months old, respectively, were infected with a 0.1 LD50 of influenza A/Taiwan/1/86 (A/H1N1) virus by small particle aerosol. Lung virus titers were determined 4, 6, 8, 12, and 17 days later. Old mice had significantly higher virus titers than young mice (P < 0.05-0.0001) and shed virus up to Day 17, while young mice were free of virus by Day 12. Splenic MHC class I CD8+ CTL activity (P < 0.08--0.001) and IFN-gamma production (0.1-0.008) measured on Days 8, 12, and 17 were significantly lower among old mice than among young mice. Coadministration of liposomal influenza vaccine with monophosphoryl lipid A (MPL) resulted in enhanced CD8+ CTL response and IFN-gamma production among old mice (35 and 12,000 times, respectively). These results demonstrate that MPL stimulates CTL and Th1 cytokines (IFN-gamma) in aged mice and may serve to reverse age-related CD8+ CTL deficiency and reduce severe influenza disease in elderly human populations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871602     DOI: 10.1006/cimm.1996.0252

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.

Authors:  W Soo Hoo; E R Jensen; A Saadat; D Nieto; R B Moss; D J Carlo; T Moll
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Authors:  N K Childers; K L Miller; G Tong; J C Llarena; T Greenway; J T Ulrich; S M Michalek
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

4.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 5.  CD8 T cell responses to influenza virus infection in aged mice.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Ageing Res Rev       Date:  2011-02-15       Impact factor: 10.895

6.  Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus.

Authors:  S N Han; D Wu; W K Ha; A Beharka; D E Smith; B S Bender; S N Meydani
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

7.  A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.

Authors:  Rhea N Coler; Susan L Baldwin; Narek Shaverdian; Sylvie Bertholet; Steven J Reed; Vanitha S Raman; Xiuhua Lu; Joshua DeVos; Kathy Hancock; Jacqueline M Katz; Thomas S Vedvick; Malcolm S Duthie; Christopher H Clegg; Neal Van Hoeven; Steven G Reed
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.

Authors:  Stacie L Lambert; Shahin Aslam; Elizabeth Stillman; Mia MacPhail; Christine Nelson; Bodrey Ro; Rosemary Sweetwood; Yuk Man Lei; Jennifer C Woo; Roderick S Tang
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.

Authors:  Shu-Ting Ren; Xue-Mei Zhang; Peng-Fei Sun; Li-Juan Sun; Xue Guo; Tian Tian; Jian Zhang; Qi-Yuan Guo; Xue Li; Li-Jun Guo; Jin Che; Bing Wang; Hui Zhang
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

10.  Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes.

Authors:  Innocent N Mbawuike; Yongxin Zhang; Robert B Couch
Journal:  Respir Res       Date:  2007-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.